Dr. John E Fitzgerald MD

Recommended Articles

• A Mother Shares How She Stays Strong for her Child with Cystic Fibrosis

  Any parent of a child with cystic fibrosis knows how difficult it can be to stay strong. Seeing a child suffer from a disease that is simply just unfair would be challenging for any parent.Kat is the mother of a girl with cystic fibrosis. She shares how she stays strong to be the rock and support...

• What Are the Causes and Symptoms of COPD?

  Chronic obstructive pulmonary disease or COPD is a lung disease that affects breathing. Airflow to the organ is blocked due to the damage to lungs....

• The Cystic Fibrosis Foundation Compass and How They Can Help

  Life with cystic fibrosis (CF) can be draining, time-consuming, and frankly – quite expensive. A majority of people living with CF, as well as their families, are faced with complex issues, such as insurance hassles, when it comes to accessing the specialized care that they require. Although CF...

• Is Legionnaires' Disease a Serious Medical Condition?

  Legionella bacteriaLegionnaires' disease is a type of pneumonia that is in its most severe form. The disease occurs due to a bacterial infection caused by a bacteria called legionella and mainly results in the inflammation of the lungs. The bacteria are known to thrive commonly in areas such as...

• It’s Important: What People With CF Want Their Doctors to Know

  Doctors and nurses are a group of professionals that are vital to patients’ health. Often times, such as when dealing with a chronic condition like cystic fibrosis (CF), some of these professionals can become like family due to how frequently you see them. And in a majority of cases, through...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...